XML 10 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
OPERATING SEGMENT AND GEOGRAPHIC INFORMATION (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
operating_segments
Jun. 30, 2011
Jun. 30, 2012
operating_segments
Dec. 31, 2011
Segment Reporting Information [Line Items]            
Number of operating segments (in operating segments)     3   3  
Net sales $ 9,093 $ 7,667 $ 16,299 $ 15,148    
Gross profit 4,562 4,555 7,666 8,742    
Net income (loss) before taxes (593) (6,102) (3,285) (8,886)    
Income tax benefit (30) (104) (26) (110)    
NET LOSS (563) (5,998) (3,259) (8,776)    
Depreciation/Amortization 532 499 1,045 992    
Restructure 0 11 0 35    
Interest expense, net (231) (240) (504) (478)    
Total Assets 44,672 30,700 44,672 30,700 44,672 33,562
Clinical laboratories
            
Segment Reporting Information [Line Items]            
Net sales 5,460 3,864 8,831 7,351    
Gross profit 3,035 2,429 4,308 4,328    
Net income (loss) before taxes (446) (5,456) (2,614) (8,745)    
Income tax benefit 0 0 0 0    
NET LOSS (446) (5,456) (2,614) (8,745)    
Depreciation/Amortization 431 407 847 801    
Restructure   0 0 0    
Interest expense, net (215) (240) (462) (473)    
Total Assets 29,082 20,663 29,082 20,663 29,082  
Pharmacogenomic services
            
Segment Reporting Information [Line Items]            
Net sales 348 1,002 978 1,272    
Gross profit 82 635 456 522    
Net income (loss) before taxes (178) (287) (97) (534)    
Income tax benefit 0 0 0 0    
NET LOSS (178) (287) (97) (534)    
Depreciation/Amortization 36 37 68 71    
Restructure   0 0 0    
Interest expense, net (6) 0 (11) 0    
Total Assets 2,019 1,958 2,019 1,958 2,019  
Diagnostic tools
            
Segment Reporting Information [Line Items]            
Net sales 3,285 2,801 6,490 6,525    
Gross profit 1,445 1,491 2,902 3,892    
Net income (loss) before taxes 31 (359) (574) 393    
Income tax benefit (30) (104) (26) (110)    
NET LOSS 61 (255) (548) 503    
Depreciation/Amortization 65 55 130 120    
Restructure   11 0 35    
Interest expense, net (10) 0 (31) (5)    
Total Assets 13,571 8,079 13,571 8,079 13,571  
United states
            
Segment Reporting Information [Line Items]            
Net sales 6,847 5,669 11,571 10,705    
Italy
            
Segment Reporting Information [Line Items]            
Net sales 907 785 1,706 1,611    
United kingdom
            
Segment Reporting Information [Line Items]            
Net sales 232 233 567 491    
All other countries
            
Segment Reporting Information [Line Items]            
Net sales $ 1,107 $ 980 $ 2,455 $ 2,341    
Maximum | All Other Countries [Member]
            
Segment Reporting Information [Line Items]            
Percent of revenue from countries not separately disclosed     5.00%      
Minimum | United states
            
Segment Reporting Information [Line Items]            
Long-lived asset percentage held in a specific location 95.00%   95.00%   95.00%